UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 172

Sortiert nach

The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations

Oral oncology, 2016-05, Vol.56, p.84-92

2016

Link zum Volltext

Verfügbarkeit prüfen

Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT

Oncoimmunology, 2019-07, Vol.8 (7), p.1593805

2019

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy Approaches in HPV-Associated Head and Neck Cancer

Cancers, 2021-12, Vol.13 (23), p.5889

2021

Link zum Volltext

Verfügbarkeit prüfen

Promising systemic immunotherapies in head and neck squamous cell carcinoma

Oral oncology, 2013-12, Vol.49 (12), p.1089-1096

2013

Link zum Volltext

Verfügbarkeit prüfen

Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition

The lancet oncology, 2013-07, Vol.14 (8), p.e302-e309

2013

Link zum Volltext

Verfügbarkeit prüfen

Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma

The Journal of clinical investigation, 2016-01, Vol.126 (1), p.169-180

2016

Link zum Volltext

Verfügbarkeit prüfen

Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations

Cancer, 2016-10, Vol.122 (20), p.3136-3144

2016

Link zum Volltext

Verfügbarkeit prüfen

Molecular and Clinical Activity of CDX-3379, an Anti-ErbB3 Monoclonal Antibody, in Head and Neck Squamous Cell Carcinoma Patients

Clinical cancer research, 2019-10, Vol.25 (19), p.5752-5758

2019

Link zum Volltext

Verfügbarkeit prüfen

Cisplatin and Radiotherapy With or Without Erlotinib in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Phase II Trial

Journal of clinical oncology, 2013-04, Vol.31 (11), p.1415-1421

2013

Link zum Volltext

Verfügbarkeit prüfen

A Prospective Phase 2 Trial of Reirradiation With Stereotactic Body Radiation Therapy Plus Cetuximab in Patients With Previously Irradiated Recurrent Squamous Cell Carcinoma of the Head and Neck

International journal of radiation oncology, biology, physics, 2015-03, Vol.91 (3), p.480-488

2015

Link zum Volltext

Verfügbarkeit prüfen

Molecular Characterization of Apocrine Salivary Duct Carcinoma

The American journal of surgical pathology, 2015-06, Vol.39 (6), p.744-752

2015

Link zum Volltext

Verfügbarkeit prüfen

MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors

PLoS pathogens, 2021-01, Vol.17 (1), p.e1009216

2021

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma

The Journal of clinical investigation, 2021-11, Vol.131 (22), p.1-15

2021

Link zum Volltext

Verfügbarkeit prüfen

Integrating Immunotherapy into Multimodal Treatment of Head and Neck Cancer

Cancers, 2023-01, Vol.15 (3), p.672

2023

Link zum Volltext

Verfügbarkeit prüfen

Prevention of Carcinogen-Induced Oral Cancer by Sulforaphane

Cancer prevention research (Philadelphia, Pa.), 2016-07, Vol.9 (7), p.547-557

2016

Link zum Volltext

Verfügbarkeit prüfen

Current Concepts in Chemotherapy for Head and Neck Cancer

Oral and maxillofacial surgery clinics of North America, 2019-02, Vol.31 (1), p.145-154

2019

Link zum Volltext

Verfügbarkeit prüfen

Targeted CUL4A inhibition synergizes with cisplatin to yield long-term survival in models of head and neck squamous cell carcinoma through a DDB2-mediated mechanism

Cell death & disease, 2022-04, Vol.13 (4), p.350-13, Article 350

2022

Link zum Volltext

Verfügbarkeit prüfen

Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer

International journal of radiation oncology, biology, physics, 2016-07, Vol.95 (3), p.973-980

2016

Link zum Volltext

Verfügbarkeit prüfen

Proteomic Characterization of Head and Neck Cancer Patient-Derived Xenografts

Molecular cancer research, 2016-03, Vol.14 (3), p.278-286

2016

Link zum Volltext

Verfügbarkeit prüfen

Head and neck squamous cell carcinoma

Nature reviews. Disease primers, 2020-11, Vol.6 (1), p.92-92, Article 92

2020

Link zum Volltext

Verfügbarkeit prüfen

Targeting NEDDylation as a Novel Approach to Improve the Treatment of Head and Neck Cancer

Cancers, 2021-06, Vol.13 (13), p.3250

2021

Link zum Volltext

Verfügbarkeit prüfen

Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors

Journal for immunotherapy of cancer, 2022-08, Vol.10 (8), p.e005147

2022

Link zum Volltext

Verfügbarkeit prüfen

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes

The Annals of thoracic surgery, 2008-11, Vol.86 (5), p.1632-1639

2008

Link zum Volltext

Verfügbarkeit prüfen

Erlotinib, Erlotinib-Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer

Clinical cancer research, 2014-06, Vol.20 (12), p.3289-3298

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 172

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(163)
Mit Volltextzugriff
(159)

Publikationsform

Sprache

Englisch
(172)
Japanisch
(21)

Erscheinungsjahr

n.n

Thema

Science & Technology
(101)
Life Sciences & Biomedicine
(100)
Humans
(77)
Oncology
(63)
Female
(43)
Male
(42)
Middle Aged
(29)
Aged
(28)
Tumors
(27)
Patients
(21)
Adult
(20)
Head & Neck Cancer
(19)
Squamous Cell Carcinoma
(19)
Head And Neck Neoplasms - Drug Therapy
(17)
Immunotherapy
(17)
Biological And Medical Sciences
(16)
Chemotherapy
(16)
Clinical Trials
(16)
Human Papillomavirus
(16)
Animals
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(37)
Clinical Cancer Research
(14)
Cancer Research
(9)
Cancers
(9)
Cancer
(8)
Oral Oncology
(5)
Bmc Cancer
(4)
Cancer Prevention Research
(4)
Head & Neck
(4)
International Journal Of Radiation Oncology, Biology, Physics
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations

Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT

Immunotherapy Approaches in HPV-Associated Head and Neck Cancer

Promising systemic immunotherapies in head and neck squamous cell carcinoma

Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition

Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma

Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations

Molecular and Clinical Activity of CDX-3379, an Anti-ErbB3 Monoclonal Antibody, in Head and Neck Squamous Cell Carcinoma Patients

Cisplatin and Radiotherapy With or Without Erlotinib in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Phase II Trial

A Prospective Phase 2 Trial of Reirradiation With Stereotactic Body Radiation Therapy Plus Cetuximab in Patients With Previously Irradiated Recurrent Squamous Cell Carcinoma of the Head and Neck

Molecular Characterization of Apocrine Salivary Duct Carcinoma

MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors

Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma

Integrating Immunotherapy into Multimodal Treatment of Head and Neck Cancer

Prevention of Carcinogen-Induced Oral Cancer by Sulforaphane

Current Concepts in Chemotherapy for Head and Neck Cancer

Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting

Targeted CUL4A inhibition synergizes with cisplatin to yield long-term survival in models of head and neck squamous cell carcinoma through a DDB2-mediated mechanism

Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer

Proteomic Characterization of Head and Neck Cancer Patient-Derived Xenografts

Head and neck squamous cell carcinoma

Targeting NEDDylation as a Novel Approach to Improve the Treatment of Head and Neck Cancer

Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes

Erlotinib, Erlotinib-Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer

Suchergebnisse filtern